ARRY - Has an option to co-promote the drug. The company now has about 130 million in cash and around 120 M in debt (??) and if it opens at around 3 tomorrow will have a MC of around 150 million. It definitely appears to be a much better investment now assuming more partnerships are around the corner. I like the fact that MGMT delivered on schedule. Still waiting for ARYX management to complete a Budiodarone deal that was supposed to be done 6 months ago.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.